Wells Fargo & Company Pliant Therapeutics, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 93,232 shares of PLRX stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

93,232

Previous 80,226 16.21%

Holding current value

$1.15 Million

Previous $862,000 21.23%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.52 - $14.35 $136,823 - $186,636	13,006 Added 16.21%	93,232 $1.05 Million
Q2 2024 Aug 13, 2024	BUY	$10.58 - $15.61 $93,908 - $138,554	8,876 Added 12.44%	80,226 $862,000
Q1 2024 May 10, 2024	BUY	$14.14 - $19.59 $30,825 - $42,706	2,180 Added 3.15%	71,350 $1.06 Million
Q4 2023 Feb 09, 2024	BUY	$12.85 - $19.15 $661,363 - $985,612	51,468 Added 290.75%	69,170 $1.25 Million
Q3 2023 Nov 13, 2023	SELL	$14.58 - $20.15 $101,097 - $139,720	-6,934 Reduced 28.15%	17,702 $306,000
Q2 2023 Aug 15, 2023	BUY	$18.12 - $30.56 $422,087 - $711,864	23,294 Added 1735.77%	24,636 $446,000
Q1 2023 May 12, 2023	BUY	$18.73 - $36.26 $20,846 - $40,357	1,113 Added 486.03%	1,342 $35,000
Q4 2022 Feb 13, 2023	SELL	$17.0 - $25.43 $3,468 - $5,187	-204 Reduced 47.11%	229 $4,000
Q3 2022 Nov 14, 2022	BUY	$7.67 - $24.23 $575 - $1,817	75 Added 20.95%	433 $9,000
Q2 2022 Aug 12, 2022	SELL	$4.11 - $8.75 $7,632 - $16,248	-1,857 Reduced 83.84%	358 $3,000
Q1 2022 May 16, 2022	SELL	$7.01 - $14.1 $59,606 - $119,892	-8,503 Reduced 79.33%	2,215 $15,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.26 $128,933 - $191,876	10,508 Added 5003.81%	10,718 $145,000
Q3 2021 Nov 15, 2021	SELL	$16.48 - $28.98 $684,513 - $1.2 Million	-41,536 Reduced 99.5%	210 $4,000
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $299,966 - $403,056	10,694 Added 34.44%	41,746 $1.22 Million
Q1 2021 May 13, 2021	BUY	$24.52 - $40.23 $376,382 - $617,530	15,350 Added 97.76%	31,052 $1.22 Million
Q4 2020 Feb 09, 2021	BUY	$19.89 - $32.99 $152,357 - $252,703	7,660 Added 95.25%	15,702 $357,000
Q3 2020 Nov 05, 2020	BUY	$21.54 - $29.53 $173,224 - $237,480	8,042 New	8,042 $182,000

Others Institutions Holding PLRX

# of Institutions

168

Shares Held

63.2M

Call Options Held

245K

Put Options Held

373K

View Full List

About PLIANT THERAPEUTICS, INC.

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

More about PLRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Pliant Therapeutics, Inc. Transaction History